Latest Period
n/a
Security Snapshot
Tiziana Life Sciences Ltd - Common (TLSA) Institutional Ownership
CUSIP: 88875G101
13F Institutional Holders and Ownership History from Q4 2018 to Q3 2024
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common
- Symbol
- TLSA on Nasdaq
- Shares outstanding
- 119,934,648
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- TLSA - Tiziana Life Sciences Ltd - Common is tracked under CUSIP 88875G101.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q2 2024 and Q3 2024.
- Reported value moved from $309,000 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
88875G101
Latest holder period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
TLSA full holder history
Tiziana Life Sciences Ltd SEC filings
Tiziana Life Sciences Ltd company facts
Tiziana Life Sciences Ltd insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 88875G101:
Significant Owners of Tiziana Life Sciences Ltd - Common (TLSA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fonda Laura Natalia Monica | 5.7% | 6,805,556 | LAURA NATALIA MONICA FONDA | 12 Sep 2025 | ||||
| Chernett Jorey | 5.4% | +8% | 6,476,471 | +8.8% | Chernett Jorey | 30 Sep 2025 |
Institutional Holders of Tiziana Life Sciences Ltd - Common (TLSA) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q3 | 0 | $0 | -$309,000 | 0 | |
| 2024 Q2 | 4,589 | $309,000 | +$309,000 | $67.33 | 1 |
| 2021 Q4 | 0 | $0 | -$2,036,000 | 0 | |
| 2021 Q3 | 1,396,352 | $2,037,000 | -$9,797,631 | $1.46 | 17 |
| 2021 Q2 | 5,573,024 | $13,066,000 | +$1,047,759 | $2.34 | 20 |
| 2021 Q1 | 5,100,890 | $14,130,000 | -$2,669,910 | $2.77 | 20 |
| 2020 Q4 | 6,405,883 | $12,937,000 | +$510,785 | $2.02 | 21 |
| 2020 Q3 | 5,015,570 | $16,707,000 | +$12,065,472 | $3.33 | 21 |
| 2020 Q2 | 1,380,255 | $9,853,000 | +$1,174,549 | $6.42 | 9 |
| 2020 Q1 | 1,212,699 | $3,605,000 | -$49,761 | $2.10 | 6 |
| 2019 Q4 | 1,248,392 | $4,339,000 | +$2,002,563 | $2.70 | 5 |
| 2019 Q3 | 619,290 | $4,184,000 | +$311,641 | $6.13 | 4 |
| 2019 Q2 | 601,163 | $4,645,000 | -$54,383 | $12.50 | 3 |
| 2019 Q1 | 615,259 | $3,888,000 | +$1,556,351 | $6.06 | 4 |
| 2018 Q4 | 385,274 | $2,868,000 | +$2,868,000 | $7.34 | 2 |